Tsuyoshi Inoue
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tsuyoshi Inoue has a total of 153 co-authors. Here are the top co-authors by number of shared publications:
- Chia-Hsien Wu
Department of Physiology of Visceral Function and Body Fluid, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
9 shared publications Masaomi Nangaku
Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan
7 shared publications- Yasuna Nakamura
Department of Physiology of Visceral Function and Body Fluid, Graduate School of Biomedical Sciences, Nagasaki University
7 shared publications Yasuna Nakamura
Department of Physiology of Visceral Function and Body Fluid, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
6 shared publicationsReiko Inagi
Division of CKD Pathophysiology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan
5 shared publicationsRie Uni
Division of CKD Pathophysiology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan
5 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Elsevier in The Journal of Physiological Sciences
- Vol. 76  (3)
Circulatory context determines the anti-inflammatory efficacy of post-sepsis vagus nerve stimulation
- 15 October 2026
- Published by Elsevier in The Journal of Physiological Sciences
- Vol. 76  (3)
Open AccessCirculatory context determines the anti-inflammatory efficacy of post-sepsis vagus nerve stimulation
- 21 August 2026
- Published by American Physiological Society in Physiology
Non-neuronal acetylcholine: from cellular signaling to clinical implications
For over a century, acetylcholine (ACh) was viewed primarily as a wired neurotransmitter of cholinergic nerves. However, accumulating evidence supports the view of the non-neuronal cholinergic system (NNCS) as an evolutionarily ancient autocrine and paracrine network operating across peripheral tissues. Rather than an extension of neuronal signaling, non-neuronal ACh can be viewed as a tissue-embedded chemical communication system positioned at the interface of cellular homeostasis and systemic neural reflexes. This review frames the NNCS as a network of tissue-resident ACh-producing cells that operates through mechanisms distinct from autonomic neural circuits. Across cardiovascular, immune, epithelial, metabolic, reproductive, and renal systems, NNCS signaling couples local cues to adaptive cellular responses. In the endothelium, ACh translates shear stress into M3 receptor-driven Ca2+ oscillations, endothelial nitric oxide synthase activation, and flow-mediated dilation, with indirect readouts of vascular cholinergicânitric oxide coupling. In inflammatory and metabolic niches, macrophage-derived ACh regulates adipose tissue inflammation, supports peritoneal macrophage efferocytosis, and engages Îą7 nicotinic receptor pathways implicated in organ protection. At mucosal surfaces, brush/tuft cell signaling contributes to chemosensation, mucociliary clearance, luminal ACh release, anti-helminth immunity, and gutâbrain communication. Non-neuronal ACh also modulates gametogenesis, placental transport, embryonic development, stem cell fitness, and conserved developmental mechanisms in honeybees. The kidney provides an informative example of layered regulation, where podocyte-derived ACh and tubular cholinergic receptor signaling are distinguished from vagusâspleen renal protective pathways and pelvic parasympathetic afferents regulating blood pressure. Finally, we address outstanding questions regarding ACh release, extracellular stability, spatial range, biomarkers, and tissue-selective therapeutic targeting.
- 21 August 2026
- Published by American Physiological Society in Physiology
Non-neuronal acetylcholine: from cellular signaling to clinical implications
For over a century, acetylcholine (ACh) was viewed primarily as a wired neurotransmitter of cholinergic nerves. However, accumulating evidence supports the view of the non-neuronal cholinergic system (NNCS) as an evolutionarily ancient autocrine and paracrine network operating across peripheral tissues. Rather than an extension of neuronal signaling, non-neuronal ACh can be viewed as a tissue-embedded chemical communication system positioned at the interface of cellular homeostasis and systemic neural reflexes. This review frames the NNCS as a network of tissue-resident ACh-producing cells that operates through mechanisms distinct from autonomic neural circuits. Across cardiovascular, immune, epithelial, metabolic, reproductive, and renal systems, NNCS signaling couples local cues to adaptive cellular responses. In the endothelium, ACh translates shear stress into M3 receptor-driven Ca2+ oscillations, endothelial nitric oxide synthase activation, and flow-mediated dilation, with indirect readouts of vascular cholinergicânitric oxide coupling. In inflammatory and metabolic niches, macrophage-derived ACh regulates adipose tissue inflammation, supports peritoneal macrophage efferocytosis, and engages Îą7 nicotinic receptor pathways implicated in organ protection. At mucosal surfaces, brush/tuft cell signaling contributes to chemosensation, mucociliary clearance, luminal ACh release, anti-helminth immunity, and gutâbrain communication. Non-neuronal ACh also modulates gametogenesis, placental transport, embryonic development, stem cell fitness, and conserved developmental mechanisms in honeybees. The kidney provides an informative example of layered regulation, where podocyte-derived ACh and tubular cholinergic receptor signaling are distinguished from vagusâspleen renal protective pathways and pelvic parasympathetic afferents regulating blood pressure. Finally, we address outstanding questions regarding ACh release, extracellular stability, spatial range, biomarkers, and tissue-selective therapeutic targeting.
- Open Access
- 11 February 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123  (7)
Abdominal ultrasound activates afferent vagus nerve fibers and induces anti-inflammatory effects
Abdominal ultrasound has emerged as a noninvasive modality with immunomodulatory potential. Although its anti-inflammatory effects have been demonstrated in various disease models, the underlying mechanisms remain unclear. Previous studies suggest that ultrasound promotes anti-inflammatory macrophage polarization via Îą7 nicotinic acetylcholine receptor (Îą7nAChR) signaling in the spleen. However, the upstream events initiating this response have not been elucidated. Here, we demonstrate that abdominal ultrasound activates afferent vagal fibers and suppress systemic inflammation. In a murine model of lipopolysaccharide (LPS)-induced endotoxemia, abdominal ultrasound significantly reduced plasma TNF-Îą levels. This anti-inflammatory effect was attenuated by subdiaphragmatic vagotomy (SDVx) or afferent vagal blockade. Electrophysiological recordings revealed increased cervical vagus nerve activity during ultrasound stimulation, which was eliminated by intraperitoneal lidocaine, confirming activation of abdominal sensory afferents. Furthermore, abdominal ultrasound induced c-Fos expression in the nucleus tractus solitarius (NTS), consistent with central activation via vagal afferent input. These findings provide direct mechanistic evidence that abdominal ultrasound stimulates afferent vagal pathways.
- 11 February 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123  (7)
Open AccessAbdominal ultrasound activates afferent vagus nerve fibers and induces anti-inflammatory effects
Abdominal ultrasound has emerged as a noninvasive modality with immunomodulatory potential. Although its anti-inflammatory effects have been demonstrated in various disease models, the underlying mechanisms remain unclear. Previous studies suggest that ultrasound promotes anti-inflammatory macrophage polarization via Îą7 nicotinic acetylcholine receptor (Îą7nAChR) signaling in the spleen. However, the upstream events initiating this response have not been elucidated. Here, we demonstrate that abdominal ultrasound activates afferent vagal fibers and suppress systemic inflammation. In a murine model of lipopolysaccharide (LPS)-induced endotoxemia, abdominal ultrasound significantly reduced plasma TNF-Îą levels. This anti-inflammatory effect was attenuated by subdiaphragmatic vagotomy (SDVx) or afferent vagal blockade. Electrophysiological recordings revealed increased cervical vagus nerve activity during ultrasound stimulation, which was eliminated by intraperitoneal lidocaine, confirming activation of abdominal sensory afferents. Furthermore, abdominal ultrasound induced c-Fos expression in the nucleus tractus solitarius (NTS), consistent with central activation via vagal afferent input. These findings provide direct mechanistic evidence that abdominal ultrasound stimulates afferent vagal pathways.
- Open Access
- 14 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15  (1) , 40005
Îą7 nicotinic acetylcholine receptor agonist attenuates lipopolysaccharide-induced acute kidney injury in mice by reducing CCL2 expression in macrophages
Sepsis-induced acute kidney injury (AKI) is associated with a high mortality rate and presents a significant clinical challenge. However, effective treatment measures have not yet been established. The cholinergic anti-inflammatory pathway (CAP), a neural mechanism that regulates immune responses, has been reported to mitigate kidney injury. Although numerous studies have demonstrated the benefits of CAP activation prior to injury, its therapeutic potential after the onset of injury remains insufficiently explored. Therefore, this study aimed to evaluate the renoprotective effects of CAP activation after the onset of lipopolysaccharide (LPS)-induced AKI. LPS (5 mg/kg) was administered to C57BL/6 wild-type mice to induce AKI. Subsequently, GTS-21 (10 mg/kg), a selective Îą7 nicotinic acetylcholine receptor agonist, was administered to assess its anti-inflammatory and renoprotective effects. In RAW 264.7 and U937-derived macrophages, LPS-induced inflammation was treated with GTS-21, and its effects were evaluated. RNA sequencing was performed to elucidate the underlying molecular mechanisms. Even after the onset of LPS-induced AKI, the administration of GTS-21 demonstrated anti-inflammatory and renoprotective effects. In macrophages, the LPS-induced increase in TNF-Îą was suppressed by GTS-21 (50 ÎźM) administration. Furthermore, CCL2 expression in macrophages might be involved in mediating these effects.
- 14 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15  (1) , 40005
Open AccessÎą7 nicotinic acetylcholine receptor agonist attenuates lipopolysaccharide-induced acute kidney injury in mice by reducing CCL2 expression in macrophages
Sepsis-induced acute kidney injury (AKI) is associated with a high mortality rate and presents a significant clinical challenge. However, effective treatment measures have not yet been established. The cholinergic anti-inflammatory pathway (CAP), a neural mechanism that regulates immune responses, has been reported to mitigate kidney injury. Although numerous studies have demonstrated the benefits of CAP activation prior to injury, its therapeutic potential after the onset of injury remains insufficiently explored. Therefore, this study aimed to evaluate the renoprotective effects of CAP activation after the onset of lipopolysaccharide (LPS)-induced AKI. LPS (5 mg/kg) was administered to C57BL/6 wild-type mice to induce AKI. Subsequently, GTS-21 (10 mg/kg), a selective Îą7 nicotinic acetylcholine receptor agonist, was administered to assess its anti-inflammatory and renoprotective effects. In RAW 264.7 and U937-derived macrophages, LPS-induced inflammation was treated with GTS-21, and its effects were evaluated. RNA sequencing was performed to elucidate the underlying molecular mechanisms. Even after the onset of LPS-induced AKI, the administration of GTS-21 demonstrated anti-inflammatory and renoprotective effects. In macrophages, the LPS-induced increase in TNF-Îą was suppressed by GTS-21 (50 ÎźM) administration. Furthermore, CCL2 expression in macrophages might be involved in mediating these effects.
- Open Access
- 28 October 2025
- Published by Elsevier in The Journal of Physiological Sciences
- Vol. 75  (3) , 100049
Macrophage depletion lowers blood pressure and reduces renal fibrosis progression in existing hypertension mice model
- 28 October 2025
- Published by Elsevier in The Journal of Physiological Sciences
- Vol. 75  (3) , 100049
Open AccessMacrophage depletion lowers blood pressure and reduces renal fibrosis progression in existing hypertension mice model
- Open Access
- 14 May 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 298, 118321
Thallium-induced neurocardiotoxicity in zebrafish: Protective role of adaptive UPR and DNA repair
- 14 May 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 298, 118321
Open AccessThallium-induced neurocardiotoxicity in zebrafish: Protective role of adaptive UPR and DNA repair
- 28 June 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 138, 112555
Activation of the Îą7nAChR by GTS-21 mitigates septic tubular cell injury and modulates macrophage infiltration
- 28 June 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 138, 112555
Activation of the Îą7nAChR by GTS-21 mitigates septic tubular cell injury and modulates macrophage infiltration
- 24 April 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 715, 149997
Renal macrophages induce hypertension and kidney fibrosis in Angiotensin II salt mice model
- 24 April 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 715, 149997
Renal macrophages induce hypertension and kidney fibrosis in Angiotensin II salt mice model
- 1 February 2024
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 326  (2) , F167-F177
Bone marrow stromal cell antigen-1 deficiency protects from acute kidney injury
Acute kidney injury (AKI), a serious disease for which there is no effective Federal Drug Administration-approved treatment, is associated with high mortality rates. Bone marrow stromal cell antigen-1 (Bst1) is a cell surface molecule that can cause kidney fibrosis, but its role in AKI is largely unknown. Our study showed that Bst1â/â mice revealed a protective effect against renal bilateral ischemia-reperfusion injury (IRI). Adoptive transfer studies confirmed that Bst1 expression in hematopoietic cells, especially neutrophils, contributed to renal bilateral IRI.
- 1 February 2024
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 326  (2) , F167-F177
Bone marrow stromal cell antigen-1 deficiency protects from acute kidney injury
Acute kidney injury (AKI), a serious disease for which there is no effective Federal Drug Administration-approved treatment, is associated with high mortality rates. Bone marrow stromal cell antigen-1 (Bst1) is a cell surface molecule that can cause kidney fibrosis, but its role in AKI is largely unknown. Our study showed that Bst1â/â mice revealed a protective effect against renal bilateral ischemia-reperfusion injury (IRI). Adoptive transfer studies confirmed that Bst1 expression in hematopoietic cells, especially neutrophils, contributed to renal bilateral IRI.
- 18 August 2023
- Published by Elsevier in Kidney International
- Vol. 104  (3) , 420-422
Tolerogenic dendritic cells: promising cell therapy for acute kidney injury
- 18 August 2023
- Published by Elsevier in Kidney International
- Vol. 104  (3) , 420-422
Tolerogenic dendritic cells: promising cell therapy for acute kidney injury